These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20477808)

  • 1. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
    Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
    APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
    Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
    Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
    Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
    Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal relationship of classical hodgkin lymphoma and its recurrences.
    Obermann EC; Mueller N; Rufle A; Menter T; Mueller-Garamvoelgyi E; Cathomas G; Dirnhofer S; Tzankov A
    Clin Cancer Res; 2011 Aug; 17(16):5268-74. PubMed ID: 21737506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma.
    Chang KC; Chang Y; Jones D; Su IJ
    Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients.
    Mori N; Watanabe K; Yamashita Y; Nakayama A; Yatabe Y; Narita M; Kobayashi T; Hasegawa Y; Kojima H; Nagasawa T
    Cancer; 1999 Feb; 85(4):970-9. PubMed ID: 10091777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pathogenesis of Hodgkin lymphoma.
    Farrell K; Jarrett RF
    Histopathology; 2011 Jan; 58(1):15-25. PubMed ID: 21261680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
    Macák J; Bertová M
    Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?
    Khan G
    Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas.
    Bai M; Papoudou-Bai A; Kitsoulis P; Horianopoulos N; Kamina S; Agnantis NJ; Kanavaros P
    In Vivo; 2005; 19(2):439-53. PubMed ID: 15796209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis.
    Isaacson PG; Schmid C; Pan L; Wotherspoon AC; Wright DH
    J Pathol; 1992 Jul; 167(3):267-71. PubMed ID: 1381432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.